Indian Journal of Medical Biochemistry

Register      Login

VOLUME 26 , ISSUE 3 ( September-December, 2022 ) > List of Articles


Serum Vitamin D and Uric Acid Levels in Glaucoma Patients: A Comprehensive Investigation

Pawan Kumar, Isha Malik, Sumit Sachdeva

Keywords : Glaucoma, Optic nerve, Radioimmunoassay, Uric acid, Vitamin D

Citation Information : Kumar P, Malik I, Sachdeva S. Serum Vitamin D and Uric Acid Levels in Glaucoma Patients: A Comprehensive Investigation. Indian J Med Biochem 2022; 26 (3):87-89.

DOI: 10.5005/jp-journals-10054-0211

License: CC BY-NC 4.0

Published Online: 25-08-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Objective: Glaucoma is an eye condition characterized by optic nerve damage due to inflammation and oxidative stress, often associated with increased intraocular pressure (IOP). Vitamin D, a fat-soluble vitamin with anti-inflammatory properties, and uric acid (UA), an antioxidant molecule capable of scavenging nitrogen radicals and superoxide in plasma, were the specific biomarkers of interest in this research. Therefore, the aim of this study was to assess serum levels of vitamin D and UA in glaucoma patients within the North Indian population. Materials and methods: The study enrolled 45 age and sex-matched controls and 45 glaucoma patients. Serum levels of vitamin D and UA were measured using the radioimmunoassay (RIA) and enzymatic methods, respectively. Results: The analysis revealed that the mean of vitamin D in the test group was 23.42 ± 6.56 (ng/mL), while in the control group, it was 29.28 ± 2.58 (ng/mL). Similarly, the UA level was 4.57 ± 1.19 (mg/dL) in the test and 5.87 ± 1.74 in the control. Conclusion: The present research demonstrated that the level was significantly lowered in both vitamin D and UA in glaucoma patients compared to healthy individuals. These findings emphasize the importance of routinely estimating serum vitamin D and UA in individuals suspected of having glaucoma. Additionally, the results may prove valuable for ophthalmologists in managing and monitoring patients with glaucoma.

  1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90(3):262–267. DOI: 10.1136/bjo.2005.081224.
  2. Coleman AL, Miglior. Risk factors for glaucoma onset and progression. Surv Ophthalmol 2008;53(Suppl. 1):S3–S10. DOI: 10.1016/j.survophthal.2008.08.006.
  3. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment. Arch Ophthalmol 2003;121(1):48–56. DOI: 10.1001/archopht.121.1.48.
  4. Shon K, Wollstein G, Schuman JS, et al. Prediction of glaucomatous field progression: Pointwise analysis. Curr Eye Res 2014;39:705–710. DOI: 10.3109/02713683.2013.867353.
  5. Nilforushan N. Neuroprotection in glaucoma. J Ophthalmic Vis Res 2012;7(1):91–93. PMID: 22737394.
  6. Kim TM, Kim JM, Kim JH, et al. The Relationship between vitamin D and glaucoma: A Kangbuk Samsung health study. Korean J Ophthalmol 2016;30(6):426–433. DOI: 10.3341/kjo.2016.30.6.426.
  7. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 2011;51:311–336. DOI: 10.1146/annurev-pharmtox-010510-100611.
  8. Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defence in humans against oxidant and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci U S A 1981;78(11):6858–6862. DOI: 10.1073/pnas.78.11.6858.
  9. Li S, Shao M, Li D, et al. Association of serum uric acid levels with primary open-angle glaucoma: A 5-year case–control study. Acta Ophthalmol 2019;97:e356–e363. DOI: 10.1111/aos.13789.
  10. Hollis BW, Kamerud JQ, Kurkowski A, et al. Quantification of circulating 1,25-dihydroxy vitamin D by radioimmunoassay with I125 labeled tracer. Clin Chem 1996;42(4):586–592. PMID: 8605676.
  11. Praetorius E, Poulsen H. Enzymatic determination of uric acid; with detailed directions. Scand J Clin Lab Invest 1953;5(3):273–280. DOI: 10.3109/00365515309094197.
  12. Yoo TK, Oh E, Hong S. Is vitamin D status associated with open-angle glaucoma? A cross-sectional study from South Korea. Public Health Nutr 2014;17(4):833–843. DOI: 10.1017/S1368980013003492.
  13. Goncalves A, Milea D, Gohier P, et al. Serum vitamin D status is associated with the presence but not the severity of primary open angle glaucoma. Maturitas 2015;81(4):470–474. DOI: 10.1016/j.maturitas.2015.05.008.
  14. Arar ZV, Praveček MK, Miškić B, et al. Association between serum vitamin D level and glaucoma in women. Acta Clin Croat 2016;55(2): 203–208. DOI: 10.20471/acc.2016.55.02.04.
  15. Armas LA, Dowell S, Akhter M, et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: The effect of UVB dose and skin color. J Am Academy Dermatol 2007;57(4):588–593. DOI: 10.1016/j.jaad.2007.03.004.
  16. Yang L, Ma J, Zhang X, et al. Protective role of the vitamin D receptor. Cell Immunol 2012;279(2):160–166. DOI: 10.1016/j.cellimm.2012.10.002.
  17. DeLuca GC, Kimball SM, Kolasinski J, et al. Review: The role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol 2013;39:458–484. DOI: 10.1111/nan.12020.
  18. McKinnon SJ. The cell and molecular biology of glaucoma: Common neurodegenerative pathways and relevance to glaucoma. Invest Ophthalmol Vis Sci 2012;53(5):2485–2487. DOI: 10.1167/iovs.12-9483j.
  19. Balion, C, Griffith LE, Strifler L. Vitamin D, cognition, and dementia: A systematic review and meta-analysis. Neurology 2012;79(13): 1397–1405. DOI: 10.1212/WNL.0b013e31826c197f.
  20. van der Schaft J, Koek HL, Dijkstra E, et al. The association between vitamin D and cognition: A systematic review. Ageing Res Rev 2013;12(4):1013–1023. DOI: 10.1016/j.arr.2013.05.004.
  21. Li S, Shao M, Tang B, et al. The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: A retrospective case–control study. Oncotarget 2017;8:2816–2824. DOI: 10.18632/oncotarget.13745.
  22. Vieru E, Koksal A, Mutluay B, et al. The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease. Neurol Sci 2016;37(5):743–747. DOI: 10.1007/s10072-015-2471-z.
  23. Lolekha P, Wongwan P, Kulkantrakorn K. Association between serum uric acid and motor subtypes of Parkinson's disease. J Clin Neurosci 2015;22(8):1264–1267. DOI: 10.1016/j.jocn.2015.02.015.
  24. Kim KE, Kim JM, Lee J, et al. Significant intraocular pressure associated with open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2010–2011. 2020;7:37–50. DOI: 10.1371/journal.pone.0235701.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.